<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BIO
Bio-Rad
$
()


  • Fly Intel: After-Hours Movers

    4/11/2024 - 18:23pm
  • OncoCyte, BioRad to partner on global launch of GraftAssure assay

    4/11/2024 - 17:31pm
  • Bio-Rad COO Andrew Last to retire

    4/10/2024 - 16:15pm
  • UPS upgraded, PepsiCo downgraded: Wall Street's top analyst calls

    4/3/2024 - 09:54am
  • Bio-Rad downgraded to Neutral on limited visibility at Citi

    4/3/2024 - 05:56am
  • Citi gets more bearish on Bio-Rad, downgrades shares

    4/3/2024 - 05:39am
  • Bio-Rad appoints Roop Lakkaraju EVP, CFO

    3/20/2024 - 08:41am
  • Early notable gainers among liquid option names on February 16th

    2/16/2024 - 09:55am
  • Bio-Rad sees FY24 revenue up 1%-2.5%

    2/15/2024 - 16:23pm
  • Bio-Rad reports Q4 EPS $3.10, consensus $2.82

    2/15/2024 - 16:20pm
  • Early notable gainers among liquid option names on January 26th

    1/26/2024 - 09:55am
  • Bio-Rad initiated with a Buy at UBS

    12/7/2023 - 05:18am
  • Early notable gainers among liquid option names on October 31st

    10/31/2023 - 09:55am
  • Bio-Rad reports Q3 adjusted EPS $2.33, consensus $2.78

    10/26/2023 - 16:27pm
  • Bio-Rad reports Q3 EPS $3.64, consensus $2.78

    10/26/2023 - 16:25pm
dynamic_feed Breaking News